The Influence of Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy Using Two Different Calcium Silicate-based Materials on Postoperative Pain and Success Rate in Mature Permanent Molars With Irreversible Pulpitis: A Randomized Clinical Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study evaluates the effect of two flushing agents (epigallocatechin gallate (EGCG) and sodium hypochlorite (NaOCl)) during full pulpotomy using two different calcium silicate-based materials (MTA and premixed bioceramic putty) on postoperative pain, success rate and dentin bridge thickness in mature permanent mandibular molars with irreversible pulpitis. Participants will be divided into four groups based on the flushing fluid and the pulp capping material to be used.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 40
Healthy Volunteers: t
View:

• Patients of either gender between the age group of 20-40 years.

• Systemically healthy patient (ASA I or II).

• Mature permanent mandibular molars with:

‣ Extremely deep carious lesion (caries penetrating entire thickness of dentin).

⁃ Clinical diagnosis of symptomatic irreversible pulpitis and normal periapical tissue.

• Patients who agree to provide written consent and attend for recall appointments.

Locations
Other Locations
Egypt
Faculty of Dentistry, Cairo University
RECRUITING
Cairo
Contact Information
Primary
Anan Medhat
Anan.Medhat@dentistry.cu.edu.eg
01098708303
Time Frame
Start Date: 2023-07-01
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 64
Treatments
Experimental: EGCG as a flushing fluid, MTA as a pulp capping material
Experimental: EGCG as a flushing fluid, Premixed BC putty as a pulp capping material
Experimental: NaOCl as a flushing fluid, Premixed BC putty as a pulp capping material
Active_comparator: NaOCl as a flushing fluid, MTA as a pulp capping material
Related Therapeutic Areas
Sponsors
Leads: Cairo University

This content was sourced from clinicaltrials.gov